Fact Source: Financial Supervisory Service DART
💡 Executive Summary
Hana Micron submitted a report detailing the inevitable scheduling of its Annual General Meeting of Shareholders on March 28, 2025—a designated concentrated date—due to consolidated settlement and external audit schedules.
📊 Key Disclosure Content & Financial Figures Summary
- Company Name: Hana Micron Inc.
- Scheduled Date of General Meeting: March 28, 2025
- Date of Meeting Notice (Announcement): March 11, 2025
- Reasons for Holding Meeting on Concentrated Date:
- Schedules were pre-determined based on management and external audit timelines prior to KOSDAQ Association’s announcement.
- Holding the meeting on a concentrated date became unavoidable due to the consolidated accounting schedule covering domestic and overseas subsidiaries, confirmation timeline of the external audit report, and meeting preparation.
- Other References for Investment Decision:
- Non-participant in the “Voluntary Compliance Program for Distributing Shareholder Meetings” hosted by the KOSDAQ Association.
- Designated concentrated dates for the year by KOSDAQ Association: March 21 (Fri), March 27 (Thu), and March 28 (Fri).
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Verification of Annual General Meeting Execution and Voting Outcomes
This filing discloses the reasons for holding the annual general meeting on a date with high concentration of shareholder meetings across companies. Confirming the smooth execution of the meeting on the scheduled date (March 28, 2025) is important for tracking the voting outcomes of the general meeting proposals. Further details can be verified through subsequent disclosures, including the Results of the Annual General Meeting of Shareholders.
📢 Disclaimer & Source Information
Source: This content was structured and regenerated based on official data submitted to the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).
Investment Disclaimer: This content is provided solely for information purposes and linguistic reference. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific securities. All investment decisions and financial risks rest solely with the investor.
Contact: For compliance inquiries or copyright-related issues, please contact ksb220805@gmail.com.
